1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA.

    2013 ESH/ESC Guidelines for the management of arterial hypertension

    EUROPEAN HEART JOURNAL . 34(28): 2159-2219. Nº de citas: 5484

    [doi:10.1093/eurheartj/eht151]

  • Escobar C, Barrios V.

    An evaluation of the latest evidence relating to renin-angiotensin system inhibitors

    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY . 9(7): 847-858. Nº de citas: 3

    [doi:10.1517/17425255.2013.788149]

  • Jiménez-Quevedo P, Hernando L, Gómez-Hospital JA, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo DJ, Bañuelos C, Escaned J, Gonzalo N, Fernández C, Macaya C, Sabaté M.

    Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

    EUROINTERVENTION . 9(3): 328-335. Nº de citas: 15

    [doi:10.4244/EIJV9I3A54]

  • Gomez-Lara J, Brugaletta S, Gomez-Hospital JA, Ferreiro JL, Roura G, Romaguera R, Martin-Yuste V, Masotti M, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Serruys P, Sabate M, Cequier A.

    Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction: Insights from the EXAMINATION trial

    AMERICAN HEART JOURNAL . 166(1): 119-119. Nº de citas: 6

    [doi:10.1016/j.ahj.2013.04.012]

  • Hernández Madrid A, Matía Francés R, Moro C, Zamorano J.

    Cardiac Resynchronization Therapy: Do Patient Selection and Implant Practice Vary Depending on the Volume a Center Handles?

    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY . 36(7): 863-871. Nº de citas: 2

    [doi:10.1111/pace.12135]

  • Echavarría-Pinto M, Lopes R, Gorgadze T, Gonzalo N, Hernández R, Jiménez-Quevedo P, Alfonso F, Bañuelos C, Nuñez-Gil IJ, Ibañez B, Fernández C, Fernandez-Ortiz A, García E, Macaya C, Escaned J.

    Safety and Efficacy of Intense Antithrombotic Treatment and Percutaneous Coronary Intervention Deferral in Patients With Large Intracoronary Thrombus

    AMERICAN JOURNAL OF CARDIOLOGY . 111(12): 1745-1750. Nº de citas: 9

    [doi:10.1016/j.amjcard.2013.02.027]

  • Zamorano JL, Gonçalves A.

    Three dimensional echocardiography for quantification of valvular heart disease

    Heart . 99(11): 811-818. Nº de citas: 6

    [doi:10.1136/heartjnl-2012-302046]

  • Hradec J, Zamorano J, Sutradhar S.

    Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial

    CURRENT MEDICAL RESEARCH AND OPINION . 29(6): 589-596. Nº de citas: 10

    [doi:10.1185/03007995.2013.783795]

  • Barrios V, Escobar C.

    Rosuvastatin and diabetes: when the evidences talk.

    Cardiovascular & hematological agents in medicinal chemistry . 11(2): 115-124.

  • Hernández-Madrid A, Svendsen JH, Lip GY, Van Gelder IC, Dobreanu D, Blomstrom-Lundqvist C.

    Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey

    EUROPACE . 15(6): 915-918. Nº de citas: 32

    [doi:10.1093/europace/eut143]

  • González-Corrochano R, La Fuente J, Cuevas P, Fernández A, Chen M, Sáenz de Tejada I, Angulo J.

    Ca2+-activated K+ channel (K-Ca) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction

    BRITISH JOURNAL OF PHARMACOLOGY . 169(2): 449-461. Nº de citas: 33

    [doi:10.1111/bph.12143]

  • Kim JH, Zamorano J, Erdine S, Pavia A, Al-Khadra A, Sutradhar S, Yunis C.

    Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (>= 65 years) patients in the CRUCIAL trial

    CURRENT MEDICAL RESEARCH AND OPINION . 29(5): 453-463. Nº de citas: 4

    [doi:10.1185/03007995.2013.781503]

  • Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germanò G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F.

    [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)].

    Giornale italiano di cardiologia (2006) . 14(5): 328-392.

    [doi:10.1714/1264.13964]

  • Barrios V, Escobar C.

    Can dabigatran improve blood pressure control?

    Future cardiology . 9(3): 321-323.

    [doi:10.2217/fca.13.18]

  • Miglioranza MH, Leiria TL, Haertel JC, Winkler M, Fernández-Golfin C, Zamorano JL.

    The Role of Three-Dimensional Echocardiography in Interventricular Mass Evaluation

    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES . 30(5): 125-127. Nº de citas: 3

    [doi:10.1111/echo.12161]

  • Almenar L, Zunzunegui JL, Barón G, Carrasco JI, Gómez-Doblas JJ, Comín J, Barrios V, Subirana MT, Díaz-Molina B.

    Update on Heart Failure, Heart Transplant, Congenital Heart Disease, and Clinical Cardiology

    REVISTA ESPANOLA DE CARDIOLOGIA . 66(4): 290-297. Nº de citas: 5

    [doi:10.1016/j.rec.2012.10.018]

  • Lancellotti P, Badano LP, Lang RM, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Derumeaux G, Dulgheru R, Edvardsen T, Galderisi M, Gonçalves A, Habib G, Hagendorff A, Hristova K, Kou S, Lopez T, Magne J, de la Morena G, Popescu BA, Penicka M, Rasit T, Rodrigo Carbonero JD, Salustri A, Van de Veire N, von Bardeleben RS, Vinereanu D, Voigt JU, Voilliot D, Zamorano JL, Donal E, Maurer G.

    Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study)

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 14(4): 303-308. Nº de citas: 75

    [doi:10.1093/ehjci/jet008]

  • Brotons C, Lobos JM, Royo-Bordonada MÁ, Maiques A, de Santiago A, Castellanos Á, Diaz S, Obaya JC, Pedro-Botet J, Moral I, Lizarbe V, Moreno R, Pérez A, Cordero A, Fornés-Ubeda F, Serrano-Saiz B, Camafort-Babkowski M, Elosua R, Sans S, de Pablo C, Gil-Nuñez A, de Álvaro-Moreno F, Armario P, Rico OC, Villar F, Lizcano Á.

    Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care

    BMC FAMILY PRACTICE . 14: 36-36. Nº de citas: 25

    [doi:10.1186/1471-2296-14-36]